The dispute triggered a sharp market reaction when it was first disclosed in April, with Aspen's shares plunging more than 30% the day after it issued a profit warning citing the disagreement with a ...
Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback